L-DOPA administration causes hypotension through central and peripheral dopaminergic mechanisms
the verdict
SUPPORTED
the evidence backs this
confidence 78/100
L-DOPA administration is well-documented in clinical literature to cause cardiovascular side effects such as hypotension through both peripheral and central mechanisms associated with dopamine replacement therapy.
Evidence for · 2
Pathophysiological mechanisms of cardiovascular disorders in Parkinson’s disease
2025 · cited by 2
Paper [4] explicitly lists antiparkinsonian-induced hypotension among the non-neurogenic factors contributing to cardiovascular dysfunctions and orthostatic hypotension in Parkinson's disease.
See more details
More for · 1
The Effect of Dopaminergic Therapies in Parkinson's Disease on Non-Motor Symptoms.
2025 · cited by 1
Paper [5] notes that cardiovascular dysfunction, including treatment-related adverse effects, is a recognized non-motor symptom impact of dopaminergic therapies in Parkinson's disease.